Stem cells as vectors for antitumour therapy

被引:83
|
作者
Loebinger, Michael R. [1 ]
Janes, Sam M. [1 ]
机构
[1] UCL, Ctr Resp Res, Rayne Inst, London WC1E 6JJ, England
基金
英国医学研究理事会;
关键词
MARROW STROMAL CELLS; CANCER GENE-THERAPY; ACUTE MYOCARDIAL-INFARCTION; LUNG METASTASIS MODEL; BONE-MARROW; IN-VITRO; CHEMOKINE RECEPTORS; BREAST-CANCER; TARGETED-DELIVERY; PROGENITOR CELLS;
D O I
10.1136/thx.2009.128025
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Recent research suggests that mesenchymal stem cells (MSCs) are able to migrate specifically to tumours and their metastases throughout the body. This has led to considerable excitement about the possibility of modifying these cells to express anticancer molecules and using them as specific targeted anticancer agents. However, there are concerns that systemically delivered MSCs may have non-desirable effects, and there are also many unanswered questions including the mechanism of tumour homing. This review investigates the different MSC-delivered anticancer agents, addresses the questions and concerns, and tries to place this potential therapy in future cancer management.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [21] Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer
    El-Haibi, Christelle P.
    Karnoub, Antoine E.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2010, 15 (04) : 399 - 409
  • [22] Potential implications of mesenchymal stem cells in cancer therapy
    Dai, Long-Jun
    Moniri, Mani R.
    Zeng, Zhi-Rong
    Zhou, Jeff X.
    Rayat, Jarrett
    Warnock, Garth L.
    CANCER LETTERS, 2011, 305 (01) : 8 - 20
  • [23] The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells
    Moniri, M. R.
    Dai, L-J
    Warnock, G. L.
    CANCER GENE THERAPY, 2014, 21 (01) : 12 - 23
  • [24] Muscular Dystrophy Therapy by Nonautologous Mesenchymal Stem Cells: Muscle Regeneration Without Immunosuppression and Inflammation
    Shabbir, Arsalan
    Zisa, David
    Leiker, Merced
    Johnston, Curtis
    Lin, Huey
    Lee, Techung
    TRANSPLANTATION, 2009, 87 (09) : 1275 - 1282
  • [25] Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
    Ding, Yuan
    Wang, Chenyang
    Sun, Zhongquan
    Wu, Yingsheng
    You, Wanlu
    Mao, Zhengwei
    Wang, Weilin
    PHARMACEUTICS, 2021, 13 (06)
  • [26] Using mesenchymal stem cells as a therapy for bone regeneration and repairing
    Shao, Jin
    Zhang, Weiwei
    Yang, Tieyi
    BIOLOGICAL RESEARCH, 2015, 48 : 1 - 7
  • [27] Stem Cells and Cell Replacement Therapy for Parkinson's Disease
    Sonntag, K. -C.
    Simunovic, F.
    Sanchez-Pernaute, R.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2009, (73): : 287 - 299
  • [28] Mesenchymal stromal/stem cells in drug therapy: New perspective
    Sherman, Lauren S.
    Shaker, Maran
    Mariotti, Veronica
    Rameshwar, Pranela
    CYTOTHERAPY, 2017, 19 (01) : 19 - 27
  • [29] Stem Cells in the Treatment of Stroke
    Hunter, Klaudia Urbaniak
    Yarbrough, Chester
    Ciacci, Joseph
    FRONTIERS IN BRAIN REPAIR, 2010, 671 : 105 - 116
  • [30] Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy
    Serakinci, Nedime
    Tulay, Pinar
    Kalkan, Rasime
    STEM CELLS: BIOLOGY AND ENGINEERING, 2018, 1083 : 45 - 62